Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Ingredients

Discovery & Development Business Practice

In Conversation with Andreas Gryczke of BASF at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Andreas Gryczke from BASF

Discovery & Development Business Practice

In Conversation with Matthias Bucerius of Merck KGaA at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Dr Matthias Bucerius from Merck KGaA

Discovery & Development Business Practice

In Conversation with Bernhard Paul of Johnson Matthey at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Bernhard Paul from Johnson Matthey

Discovery & Development Business Practice

In Conversation with Gary Lord of Dow Corning Healthcare at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Gary Lord from Dow Corning Healthcare

Discovery & Development Business Practice

In Conversation with Simon Edwards of Cambrex at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Simon Edwards from Cambrex

Discovery & Development Business Practice

In Conversation with Dr Jean Luc Herbeaux of Evonik at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Dr Jean Luc Herbeaux from Evonik

Manufacture Business Practice

Direct visualization, sizing and concentration measurements of drug delivery nanoparticles

In this application note, we discuss how Nanoparticle Tracking Analysis (NTA) is used to measure the size and concentration of nanoparticles used for drug delivery, such as liposomes, in order to determine efficacy and rate of uptake, degradation and clearance from the body.

Discovery & Development Business Practice

In-vitro bioequivalence studies

The Morphologi G3-ID can be used to compare the Active Pharmaceutical Ingredients (API) within oral solid dose formualtions. Here we apply it to comparing innovator and generic versions of a product containing two APIs.

Discovery & Development Contract Development Services

A False Economy

| Sven Stegemann

There is a constant drive in the industry to reduce costs, but inexpensive supplies can prove a poor bargain.

Discovery & Development Business Practice

Top five reasons to replace a viscometer with a rheometer

Is your viscometer approaching the end of its life? Are you starting to feel that your trial and error, ‘rheology-light’ approach to formulation is becoming dated? Or are there longstanding product performance issues that you’re failing to gain traction with, where you suspect rheology may hold the answer? 

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register